CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: vanadium oxide
Accession: CHEBI:35174
browse the term
Synonyms: related_synonym: vanadium oxides
G
Abcc5
ATP binding cassette subfamily C member 5
affects expression
ISO
vanadium pentoxide affects the expression of ABCC5 mRNA
CTD
PMID:26210822
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Adcy2
adenylate cyclase 2
affects expression
ISO
vanadium pentoxide affects the expression of ADCY2 mRNA
CTD
PMID:26210822
NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236
G
Adcy3
adenylate cyclase 3
affects expression
ISO
vanadium pentoxide affects the expression of ADCY3 mRNA
CTD
PMID:26210822
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
G
Adcy4
adenylate cyclase 4
affects expression
ISO
vanadium pentoxide affects the expression of ADCY4 mRNA
CTD
PMID:26210822
NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108
G
Adcy7
adenylate cyclase 7
affects expression
ISO
vanadium pentoxide affects the expression of ADCY7 mRNA
CTD
PMID:26210822
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Adcy8
adenylate cyclase 8
affects expression
ISO
vanadium pentoxide affects the expression of ADCY8 mRNA
CTD
PMID:26210822
NCBI chr 7:96,417,310...96,665,911
Ensembl chr 7:96,417,324...96,665,911
G
Arsj
arylsulfatase family, member J
affects expression
ISO
vanadium pentoxide affects the expression of ARSJ mRNA
CTD
PMID:26210822
NCBI chr 2:214,774,631...214,854,614
Ensembl chr 2:214,774,654...214,854,612
G
Bmp2
bone morphogenetic protein 2
affects expression
ISO
vanadium pentoxide affects the expression of BMP2 mRNA
CTD
PMID:17459161
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Btg1
BTG anti-proliferation factor 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of BTG1 mRNA
CTD
PMID:17459161
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
decreases expression
ISO
vanadium pentoxide results in decreased expression of BTG2 mRNA
CTD
PMID:17459161
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Casp3
caspase 3
multiple interactions increases activity
EXP
PRKCD mutant form inhibits the reaction [vanadium pentoxide results in increased activity of CASP3 protein]
CTD
PMID:19646462
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
EXP
vanadium pentoxide results in increased activity of CASP9 protein
CTD
PMID:19646462
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
vanadium pentoxide results in decreased expression of CCN2 mRNA
CTD
PMID:17459161
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccng2
cyclin G2
decreases expression
ISO
vanadium pentoxide results in decreased expression of CCNG2 mRNA
CTD
PMID:17459161
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnt2
cyclin T2
affects expression
ISO
vanadium pentoxide affects the expression of CCNT2 mRNA
CTD
PMID:17459161
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
G
Cd44
CD44 molecule
affects expression
ISO
vanadium pentoxide affects the expression of CD44 mRNA
CTD
PMID:17459161 PMID:26210822
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdc25c
cell division cycle 25C
increases expression
ISO
vanadium pentoxide results in increased expression of CDC25C protein
CTD
PMID:33913241
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdh1
cadherin 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDH1 protein
CTD
PMID:38479551
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdk7
cyclin-dependent kinase 7
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDK7 mRNA
CTD
PMID:17459161
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
G
Cdk9
cyclin-dependent kinase 9
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDK9 mRNA
CTD
PMID:17459161
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDKN1A protein
CTD
PMID:33913241
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDKN1B mRNA
CTD
PMID:17459161
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDKN1C mRNA
CTD
PMID:17459161
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
vanadium pentoxide results in decreased expression of CDKN2C mRNA
CTD
PMID:17459161
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
vanadium pentoxide results in decreased expression of COL1A1 mRNA
CTD
PMID:17459161
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
vanadium pentoxide results in decreased expression of COL1A2 mRNA
CTD
PMID:17459161
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
vanadium pentoxide results in decreased expression of COL3A1 mRNA
CTD
PMID:17459161
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Ctsa
cathepsin A
affects expression
ISO
vanadium pentoxide affects the expression of CTSA mRNA
CTD
PMID:26210822
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
G
Cx3cr1
C-X3-C motif chemokine receptor 1
increases expression
ISO
vanadium pentoxide results in increased expression of CX3CR1 mRNA
CTD
PMID:17459161
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
EXP
vanadium pentoxide results in increased expression of CXCL1 protein
CTD
PMID:9707512
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions increases expression
ISO
acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA]; Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA]
CTD
PMID:17459161 PMID:18322232
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
vanadium pentoxide results in increased expression of CXCL2 protein
CTD
PMID:9707512
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl9
C-X-C motif chemokine ligand 9
increases expression
ISO
vanadium pentoxide results in increased expression of CXCL9 mRNA
CTD
PMID:17459161
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Dusp6
dual specificity phosphatase 6
affects expression
ISO
vanadium pentoxide affects the expression of DUSP6 mRNA
CTD
PMID:17459161
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Egr1
early growth response 1
affects expression
ISO
vanadium pentoxide affects the expression of EGR1 mRNA
CTD
PMID:17459161
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr3
early growth response 3
affects expression
ISO
vanadium pentoxide affects the expression of EGR3 mRNA
CTD
PMID:17459161
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Fabp4
fatty acid binding protein 4
decreases expression
ISO
vanadium pentoxide results in decreased expression of FABP4 mRNA
CTD
PMID:26210822
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fgf2
fibroblast growth factor 2
decreases expression
ISO
vanadium pentoxide results in decreased expression of FGF2 mRNA
CTD
PMID:17459161
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgf9
fibroblast growth factor 9
decreases expression
ISO
vanadium pentoxide results in decreased expression of FGF9 mRNA
CTD
PMID:17459161
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
G
Galc
galactosylceramidase
affects expression
ISO
vanadium pentoxide affects the expression of GALC mRNA
CTD
PMID:26210822
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
G
Gas1
growth arrest-specific 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of GAS1 mRNA
CTD
PMID:17459161
NCBI chr17:4,482,168...4,485,153
G
Gata6
GATA binding protein 6
affects expression
ISO
vanadium pentoxide affects the expression of GATA6 mRNA
CTD
PMID:17459161
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Gbp1
guanylate binding protein 1
affects expression
ISO
vanadium pentoxide affects the expression of GBP1 mRNA
CTD
PMID:17459161
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gdf15
growth differentiation factor 15
increases expression
ISO
vanadium pentoxide results in increased expression of GDF15 mRNA
CTD
PMID:17459161
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gusb
glucuronidase, beta
affects expression
ISO
vanadium pentoxide affects the expression of GUSB mRNA
CTD
PMID:26210822
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Hbegf
heparin-binding EGF-like growth factor
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA]; Acetylcysteine inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA]; RTKI cpd inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA]; SB 203580 inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA] vanadium pentoxide results in increased expression of HBEGF mRNA; vanadium pentoxide results in increased expression of HBEGF protein
CTD
PMID:11159045 PMID:12676768 PMID:17459161
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hexa
hexosaminidase subunit alpha
affects expression
ISO
vanadium pentoxide affects the expression of HEXA mRNA
CTD
PMID:26210822
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
G
Hgf
hepatocyte growth factor
increases expression
ISO
vanadium pentoxide results in increased expression of HGF mRNA
CTD
PMID:17459161
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hyal2
hyaluronidase 2
affects expression
ISO
vanadium pentoxide affects the expression of HYAL2 mRNA
CTD
PMID:26210822
NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850
G
Ifnb1
interferon beta 1
multiple interactions increases expression
ISO
acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of IFNB1 mRNA]; Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of IFNB1 mRNA]; IFNB1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]
CTD
PMID:18322232
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifngr1
interferon gamma receptor 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of IFNGR1 mRNA
CTD
PMID:17459161
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il15
interleukin 15
decreases expression
ISO
vanadium pentoxide results in decreased expression of IL15 mRNA
CTD
PMID:17459161
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il6
interleukin 6
increases expression
ISO
vanadium pentoxide results in increased expression of IL6 mRNA
CTD
PMID:17459161
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf1
interferon regulatory factor 1
affects expression
ISO
vanadium pentoxide affects the expression of IRF1 mRNA
CTD
PMID:17459161
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Jak1
Janus kinase 1
multiple interactions
ISO
JAK1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]
CTD
PMID:18322232
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
decreases expression
ISO
vanadium pentoxide results in decreased expression of JAK2 mRNA
CTD
PMID:17459161
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
vanadium pentoxide results in increased expression of JUN mRNA
CTD
PMID:17459161
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Keap1
Kelch-like ECH-associated protein 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of KEAP1 mRNA
CTD
PMID:17459161
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Klf7
KLF transcription factor 7
increases expression
ISO
vanadium pentoxide results in increased expression of KLF7 mRNA
CTD
PMID:17459161
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
G
Lyst
lysosomal trafficking regulator
affects expression
ISO
vanadium pentoxide affects the expression of LYST mRNA
CTD
PMID:17459161
NCBI chr17:86,241,384...86,443,501
Ensembl chr17:86,241,384...86,443,480
G
Lyve1
lymphatic vessel endothelial hyaluronan receptor 1
affects expression
ISO
vanadium pentoxide affects the expression of LYVE1 mRNA
CTD
PMID:26210822
NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation increases activity
ISO
vanadium pentoxide results in increased phosphorylation of MAPK1 protein vanadium pentoxide results in increased activity of MAPK1 protein
CTD
PMID:12376484 PMID:12676768
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation increases activity
ISO
vanadium pentoxide results in increased phosphorylation of MAPK3 protein vanadium pentoxide results in increased activity of MAPK3 protein
CTD
PMID:12376484 PMID:12676768
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Marcks
myristoylated alanine rich protein kinase C substrate
decreases expression
ISO
vanadium pentoxide results in decreased expression of MARCKS mRNA
CTD
PMID:17459161
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Mmp2
matrix metallopeptidase 2
increases expression
ISO
vanadium pentoxide results in increased expression of MMP2 protein
CTD
PMID:18059072
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
increases expression
ISO
vanadium pentoxide results in increased expression of MMP9 protein
CTD
PMID:18059072
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mtch1
mitochondrial carrier 1
affects expression
ISO
vanadium pentoxide affects the expression of MTCH1 mRNA
CTD
PMID:26210822
NCBI chr20:7,389,942...7,413,426
Ensembl chr20:7,389,949...7,413,426
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
vanadium pentoxide results in increased expression of NAMPT mRNA
CTD
PMID:17459161
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
affects expression
ISO
vanadium pentoxide affects the expression of NEDD9 mRNA
CTD
PMID:17459161
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Neurl1
neuralized E3 ubiquitin protein ligase 1
affects expression
ISO
vanadium pentoxide affects the expression of NEURL1A mRNA
CTD
PMID:26210822
NCBI chr 1:246,066,830...246,152,890
Ensembl chr 1:246,067,100...246,152,903
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
vanadium pentoxide results in increased expression of NQO1 mRNA
CTD
PMID:17459161
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Oxr1
oxidation resistance 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of OXR1 mRNA
CTD
PMID:17459161
NCBI chr 7:72,528,750...72,965,666
Ensembl chr 7:72,528,786...72,965,666
G
Oxsr1
oxidative stress responsive kinase 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of OXSR1 mRNA
CTD
PMID:17459161
NCBI chr 8:118,972,754...119,062,102
Ensembl chr 8:118,972,754...119,062,027
G
Pdgfa
platelet derived growth factor subunit A
increases expression
EXP
vanadium pentoxide results in increased expression of PDGFA mRNA
CTD
PMID:17134509
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
increases expression
EXP
vanadium pentoxide results in increased expression of PDGFB mRNA
CTD
PMID:17134509
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfc
platelet derived growth factor C
increases expression
EXP
vanadium pentoxide results in increased expression of PDGFC mRNA
CTD
PMID:17134509
NCBI chr 2:166,316,870...166,493,449
Ensembl chr 2:166,316,803...166,493,433
G
Pdgfra
platelet derived growth factor receptor alpha
increases expression
EXP
vanadium pentoxide results in increased expression of PDGFRA mRNA
CTD
PMID:17134509
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pipox
pipecolic acid and sarcosine oxidase
increases expression
ISO
vanadium pentoxide results in increased expression of PIPOX mRNA
CTD
PMID:17459161
NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370
G
Plpp1
phospholipid phosphatase 1
affects expression
ISO
vanadium pentoxide affects the expression of PPAP2A mRNA
CTD
PMID:26210822
NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268
G
Plpp3
phospholipid phosphatase 3
affects expression
ISO
vanadium pentoxide affects the expression of PLPP3 mRNA
CTD
PMID:26210822
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Prkcd
protein kinase C, delta
multiple interactions increases expression
EXP ISO
PRKCD mutant form inhibits the reaction [vanadium pentoxide results in increased activity of CASP3 protein]; vanadium pentoxide results in increased cleavage of and results in increased activity of PRKCD protein vanadium pentoxide results in increased expression of PRKCD mRNA
CTD
PMID:19646462 PMID:26210822
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkce
protein kinase C, epsilon
affects expression
ISO
vanadium pentoxide affects the expression of PRKCE mRNA
CTD
PMID:26210822
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Sgpl1
sphingosine-1-phosphate lyase 1
affects expression
ISO
vanadium pentoxide affects the expression of SGPL1 mRNA
CTD
PMID:26210822
NCBI chr20:29,047,793...29,094,209
Ensembl chr20:29,047,796...29,094,084
G
Slc11a2
solute carrier family 11 member 2
increases expression
EXP
vanadium pentoxide results in increased expression of SLC11A2 protein
CTD
PMID:19646462
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc2a3
solute carrier family 2 member 3
affects expression
ISO
vanadium pentoxide affects the expression of SLC2A3 mRNA
CTD
PMID:17459161
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc2a4
solute carrier family 2 member 4
decreases expression
ISO
vanadium pentoxide results in decreased expression of SLC2A4 mRNA
CTD
PMID:26210822
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Smad1
SMAD family member 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of SMAD1 mRNA
CTD
PMID:17459161
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smurf1
SMAD specific E3 ubiquitin protein ligase 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of SMURF1 mRNA
CTD
PMID:17459161
NCBI chr12:9,635,009...9,726,520
Ensembl chr12:9,635,025...9,726,519
G
Socs1
suppressor of cytokine signaling 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of SOCS1 mRNA
CTD
PMID:17459161
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
vanadium pentoxide results in increased expression of SOCS3 mRNA
CTD
PMID:17459161
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
increases expression
ISO
vanadium pentoxide results in increased expression of SOD2 mRNA
CTD
PMID:17459161
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sphk1
sphingosine kinase 1
affects expression
ISO
vanadium pentoxide affects the expression of SPHK1 mRNA
CTD
PMID:26210822
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spp1
secreted phosphoprotein 1
increases expression
EXP
vanadium pentoxide results in increased expression of SPP1 mRNA
CTD
PMID:17134509
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spred2
sprouty-related, EVH1 domain containing 2
affects expression
ISO
vanadium pentoxide affects the expression of SPRED2 mRNA
CTD
PMID:17459161
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
affects expression
ISO
vanadium pentoxide affects the expression of SPTLC2 mRNA
CTD
PMID:26210822
NCBI chr 6:106,948,682...107,031,532
Ensembl chr 6:106,950,949...107,031,542
G
Stat1
signal transducer and activator of transcription 1
multiple interactions decreases expression
ISO
acetovanillone inhibits the reaction [vanadium pentoxide results in increased phosphorylation of STAT1 protein]; Allopurinol inhibits the reaction [vanadium pentoxide results in increased phosphorylation of STAT1 protein]; Hydrogen Peroxide affects the reaction [vanadium pentoxide results in increased phosphorylation of and results in increased activity of STAT1 protein]; IFNB1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]; JAK1 protein affects the reaction [vanadium pentoxide results in increased activity of STAT1 protein]; vanadium pentoxide results in increased activity of and results in increased phosphorylation of STAT1 protein vanadium pentoxide results in decreased expression of STAT1 mRNA
CTD
PMID:17459161 PMID:18322232
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stc1
stanniocalcin 1
increases expression
ISO
vanadium pentoxide results in increased expression of STC1 mRNA
CTD
PMID:17459161
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Tf
transferrin
increases expression
EXP
vanadium pentoxide results in increased expression of TF protein
CTD
PMID:19646462
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb2
transforming growth factor, beta 2
decreases expression
ISO
vanadium pentoxide results in decreased expression of TGFB2 mRNA
CTD
PMID:17459161
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tnf
tumor necrosis factor
increases expression
ISO
vanadium pentoxide results in increased expression of TNF protein
CTD
PMID:9707512
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Traf4
Tnf receptor associated factor 4
decreases expression
ISO
vanadium pentoxide results in decreased expression of TRAF4 mRNA
CTD
PMID:17459161
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
G
Ucp1
uncoupling protein 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of UCP1 mRNA
CTD
PMID:26210822
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
ISO
vanadium pentoxide results in decreased expression of VCAM1 mRNA
CTD
PMID:17459161
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
vanadium pentoxide results in increased expression of VEGFA mRNA
CTD
PMID:17459161
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Cdc25c
cell division cycle 25C
increases expression
ISO
vanadium dioxide results in increased expression of CDC25C protein
CTD
PMID:33913241
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Slc11a2
solute carrier family 11 member 2
increases transport
ISO
SLC11A2 protein results in increased transport of vanadium dioxide
CTD
PMID:22736759
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Tp53
tumor protein p53
increases expression
ISO
vanadium dioxide results in increased expression of TP53 protein
CTD
PMID:33913241
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all